Low-Dose vs Standard-Dose Indomethacin for Preventing Post-ERCP Pancreatitis

Clinical trial NCT07088757 · RECRUITING

Trial details

NCT number: NCT07088757
Sponsor: Changhai Hospital
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Post-ERCP Pancreatitis

Start date: 2025-09-15
Primary completion: 2026-11-01
Enrollment: 1366

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.